NeOnc Technologies Holdings is trading at $2.80, up 10.83%; biotech-sector strength is the likeliest context.
- At 12:46 p.m. ET on October 9, 2026, no confirmed company-specific announcement explained the gain; the earlier alert also reported no direct catalyst.
- XBI was up 2.50% in the supplied sector update, alongside positive IPO and deal sentiment. Sector-wide IPO and M&A activity has supported biotech optimism but does not establish a cause for this stock’s rise.
- No trading-volume figure was provided.